FMRP regulation of aggrecan mRNA translation controls perineuronal net development

Heleen M. van't Spijker,Joel D. Richter
DOI: https://doi.org/10.1111/jnc.16048
2024-01-17
Journal of Neurochemistry
Abstract:Fragile X Messenger Ribonucleoprotein (FMRP) regulates translational efficiency of aggrecan mRNA through the protection of its poly(A) tail. Loss of FMRP leads to a reduction of aggrecan mRNA poly(A) tail length, which decreases the number of ribosomes that bind the mRNA to initiate translation. The reduction in Aggrecan protein levels results in a delay in formation of perineuronal nets (PNNs). PNNs are necessary for the excitatory/inhibitory (E/I) balance in the brain, which is disrupted in mouse models of Fragile X Syndrome (FXS), a neurodevelopmental disorder caused by the loss of FMRP. Perineuronal nets (PNNs) are mesh‐like structures on the surfaces of parvalbumin‐expressing inhibitory and other neurons, and consist of proteoglycans such as aggrecan, brevican, and neurocan. PNNs regulate the Excitatory/Inhibitory (E/I) balance in the brain and are formed at the closure of critical periods of plasticity during development. PNN formation is disrupted in Fragile X Syndrome, which is caused by silencing of the fragile X messenger ribonucleoprotein 1 (Fmr1) gene and loss of its protein product FMRP. FXS is characterized by impaired synaptic plasticity resulting in neuronal hyperexcitability and E/I imbalance. Here, we investigate how PNN formation is altered in FXS. PNNs are reduced in Fmr1 KO mouse brain when examined by staining for the lectin Wisteria floribunda agglutin (WFA) and aggrecan. Examination of PNNs by WFA staining at P14 and P42 in the hippocampus, somatosensory cortex, and retrosplenial cortex shows that they were reduced in these brain regions at P14 but mostly less so at P42 in Fmr1 KO mice. However, some differential FMRP regulation of PNN development in these brain regions persists, perhaps caused by asynchrony in PNN development between brain regions in wild‐type animals. During development, aggrecan PNN levels in the brain were reduced in all brain regions in Fmr1 KO mice. Aggrecan mRNA levels were unchanged at these times, suggesting that FMRP is normally an activator of aggrecan mRNA translation. This hypothesis is buttressed by the observations that FMRP binds aggrecan mRNA and that ribosome profiling data show that aggrecan mRNA is associated with reduced numbers of ribosomes in Fmr1 KO mouse brain, indicating reduced translational efficiency. Moreover, aggrecan mRNA poly(A) tail length is also reduced in Fmr1 KO mouse brain, suggesting a relationship between polyadenylation and translational control. We propose a model where FMRP modulates PNN formation through translational up‐regulation of aggrecan mRNA polyadenylation and translation.
biochemistry & molecular biology,neurosciences
What problem does this paper attempt to address?